A carbohydrate-binding protein from the edible Lablab beans effectively blocks the infections of SARS-CoV-2
Updated time: 2024-07-29 09:59:20
A carbohydrate-binding protein from the edible Lablab beans effectively blocks the infections of SARS-CoV-2
Docket Number
28A-1090218
Announcement Date
2020-07-30
IP Status
TW I775426、JP 7502468
Abstract
FRIL, a plant lectin isolated from the hyacinth bean, has potent antiviral activity against SARS-CoV2. FRIL’s antiviral activity is mediated by binding to complex type N-glycans on viral glycoproteins, interfering with viral entry.
Technological Advantages
- FRIL can neutralize SARS-CoV-1 and SARS-CoV-2 viruses.
- FRIL preferentially binds to complex type N-glycans on viral glycoproteins to interfere and prevent the virus from entering host cells.
- Lablab beans can be used for food, so FRIL is safe for human.
- Low cost.
Applications of Technology
- Coat FRIL on masks or be included in aerosol mists in a closed space.
- FRIL can be used in an inhaler.

Fig1. FRIL can interfere with viral invasion.

Fig2. Immunofluorescence tracking of SARS-CoV-2 N (green) and S protein (cyan) production, with or without FRIL inhibition. Nuclei are counterstained with DAPI (blue).
Inventor
Che MA、Jia-Tsrong Jan
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

A carbohydrate-binding protein from the edible Lablab beans effectively blocks the infections of SARS-CoV-2